Phetharbital

Phetharbital
Clinical data
Other names	Phetharbital
ATC code	none;
Identifiers
	IUPAC name 1-Phenyl-5,5-diethyl-1,3-diazinane-2,4,6-trione;
CAS Number	357-67-5 ;
PubChem CID	9650;
ChemSpider	9271 ;
UNII	52HG53W51E;
CompTox Dashboard (EPA)	DTXSID30189216 ;
ECHA InfoCard	100.006.015
Chemical and physical data
Formula	C14H16N2O3
Molar mass	260.293 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c2ccccc2N(C1=O)C(=O)NC(=O)C1(CC)CC;
	InChI InChI=1S/C14H16N2O3/c1-3-14(4-2)11(17)15-13(19)16(12(14)18)10-8-6-5-7-9-10/h5-9H,3-4H2,1-2H3,(H,15,17,19) ; Key:ILORKHQGIMGDFN-UHFFFAOYSA-N ;
	(what is this?) (verify)

Phetharbital (phenetharbital) is a barbiturate derivative. It has anticonvulsant effects and relatively weak sedative action, and is considered to have a low abuse potential.^[1]

References

^ Eddy NB, Halbach H, Isbell H, Seevers MH (1965). "Drug dependence: Its significance and characteristics". Bulletin of the World Health Organization. 32 (5): 721–733. PMC 2555251. PMID 5294186.

This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it.

[1] Eddy NB, Halbach H, Isbell H, Seevers MH (1965). "Drug dependence: Its significance and characteristics". Bulletin of the World Health Organization. 32 (5): 721–733. PMC 2555251. PMID 5294186.

[1]